Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery

Drug Discovery Today

Volumn 20, Issue 2, 2015, Pages 255-261

  Kothiwale, Sandeepkumar ^a   Borza, Corina M ^a   Lowe, Edward W ^a   Pozzi, Ambra ^a,b   Meiler, Jens ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISCOIDIN DOMAIN RECEPTOR 1; DISCOIDIN DOMAIN RECEPTOR 1 INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; DISCOIDIN RECEPTOR; LECTIN RECEPTOR; PROTEIN KINASE INHIBITOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG DEVELOPMENT; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME CONFORMATION; ENZYME STRUCTURE; HUMAN; PROTEIN DOMAIN; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN;

EID: 84922939255     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.09.025     Document Type: Review

References (38)

1. H.L. Fu Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases J. Biol. Chem. 288 2013 12114 12129
2. H.L. Fu Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling J. Biol. Chem. 288 2013 7430 7437
3. W. Vogel The discoidin domain receptor tyrosine kinases are activated by collagen Mol. Cell 1 1997 13 23
4. D.H. Koo Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1 FEBS Lett. 580 2006 15 22
5. C.Z. Wang A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration Mol. Biol. Cell 17 2006 2839 2852
6. C.G. L'Hote Functional analysis of discoidin domain receptor 1: effect of adhesion on DDR1 phosphorylation FASEB J. 16 2002 234 236
7. K.K. Lu Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src Cardiovasc. Pathol. 20 2011 71 76
8. C.A. Curat, and W.F. Vogel Discoidin domain receptor 1 controls growth and adhesion of mesangial cells J. Am. Soc. Nephrol. 13 2002 2648 2656
9. H. Xu Discoidin domain receptors promote alpha1beta1- and alpha2beta1-integrin mediated cell adhesion to collagen by enhancing integrin activation PLoS ONE 7 2012 e52209
10. K. Roarty, and R. Serra Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth Development 134 2007 3929 3939
11. H.G. Kim DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation J. Biol. Chem. 286 2011 17672 17681
12. Y. Shintani Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1 J. Cell Biol. 180 2008 1277 1289
13. C.M. Borza, and A. Pozzi Discoidin domain receptors in disease Matrix Biol. 34 2014 185 192
14. W.F. Vogel Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development Mol. Cell Biol. 21 2001 2906 2917
15. C. Franco Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice Circ. Res. 102 2008 1202 1211
16. C. Avivi-Green Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis Am. J. Respir. Crit. Care Med. 174 2006 420 427
17. H. Xu Normal activation of discoidin domain receptor 1 mutants with disulphide cross-links, insertions or deletions in the extracellular juxtamembrane region: mechanistic implications J. Biol. Chem. 289 2014 13565 13574
18. H.L. Fu Glycosylation at Asn211 regulates the activation state of the discoidin domain receptor 1 (DDR1) J. Biol. Chem. 289 2014 9275 9287
19. M. Rabiller Proteus in the world of proteins: conformational changes in protein kinases Arch. Pharm. 343 2010 193 206
20. L.N. Johnson Active and inactive protein kinases: structural basis for regulation Cell 85 1996 149 158
21. P. Canning Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors J. Mol. Biol. 426 2014 2457 2470
22. S.S. Taylor, and A.P. Kornev Protein kinases: evolution of dynamic regulatory proteins Trends Biochem. Sci. 36 2011 65 77
23. A.P. Kornev, and S.S. Taylor Defining the conserved internal architecture of a protein kinase Biochim. Biophys. Acta 1804 2010 440 444
24. R.A. Norman Structural approaches to obtain kinase selectivity Trends Pharmacol. Sci. 33 2012 273 278
25. M. Bantscheff Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors Nat. Biotechnol. 25 2007 1035 1044
26. U. Rix Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets Blood 110 2007 4055 4063
27. U. Rix A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells Leukemia 24 2010 44 50
28. E. Day Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib Eur. J. Pharmacol. 599 2008 44 53
29. X. Sun LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation J. Pharmacol. Exp. Ther. 340 2012 510 519
30. M. Gao Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors J. Med. Chem. 56 2013 3281 3295
31. H.G. Kim Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor ACS Chem. Biol. 8 10 2013 2145 2150
32. Y. Liu, and N.S. Gray Rational design of inhibitors that bind to inactive kinase conformations Nat. Chem. Biol. 2 2006 358 364
33. F. Zuccotto Through the 'gatekeeper door': exploiting the active kinase conformation J. Med. Chem. 53 2010 2681 2694
34. R.M. Eglen, and T. Reisine The current status of drug discovery against the human kinome Assay Drug Dev. Technol. 7 2009 22 43
35. N. Munshi ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity Mol. Cancer Ther. 9 2010 1544 1553
36. S. Eathiraj Discovery of a novel mode of protein kinase inhibition characterized by the mechanism of inhibition of human mesenchymal-epithelial transition factor (c-Met) protein autophosphorylation by ARQ 197 J. Biol. Chem. 286 2011 20666 20676
37. K.W. Kaufmann Practically useful: what the ROSETTA protein modeling suite can do for you Biochemistry 49 2010 2987 2998
38. M.I. Davis Comprehensive analysis of kinase inhibitor selectivity Nat. Biotechnol. 29 2011 1046 1051